Mass General Brigham, Inc
- SEC CIK
- 0001678378
- Latest filing
- Aug 7, 2026
Holdings in Q4 2025
Holdings as of Dec 31, 2025, filed Jan 27, 2026. Long positions only.
- Positions
- 7
- No filing for Q3 2025
- Portfolio value
- $809.8M
- No filing for Q3 2025
Mass General Brigham, Inc did not file a 13F for Q3 2025, so these holdings cannot be compared with the previous quarter and changes are not shown.
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| iShares Tr464288257 | MSCI ACWI ETF | 4,613,955 | $652.8M | 80.6% | – | – | – |
| KRMNKarman Holdings Inc. | COMMON STOCK | 1,562,054 | $114.3M | 14.1% | – | – | History |
| RVMDRevolution Medicines, Inc. | COM | 344,091 | $27.4M | 3.4% | – | – | History |
| MAZEMaze Therapeutics, Inc. | COM | 239,994 | $9.94M | 1.2% | – | – | History |
| TNGXTango Therapeutics, Inc. | COM | 354,192 | $3.14M | 0.4% | – | – | History |
| MDLNMedline Inc. | COM CL A | 26,294 | $1.10M | 0.1% | – | – | History |
| RBRKRubrik, Inc. | Stock | 14,000 | $1.07M | 0.1% | – | – | History |